Myrexis, Inc. (MYRX) 은(는) 상장 기업입니다 금융 섹터의 Shell Companies 산업에서 운영. 본사 소재지는 New York City, NY, 미국. 현재 CEO는 Jonathan Couchman.
MYRX 을(를) 보유 IPO 날짜 2009-06-12, 1 명의 정규직 직원, 에 상장 Other OTC, 시가총액 $20.69K.
Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis, Inc. is headquartered in New York, New York.
